The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EAGLE: A phase 3, randomized, open-label study of durvalumab (D) with or without tremelimumab (T) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC).
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen and Nanobiotics Sa; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Doxapharma; Eisai; Health & Life srl; Immuno-Oncology Hub; Incyte; Ipsen; Kura Oncology; Merck Serono; MSD; Novartis; Roche; SOBI
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Exelixis (Inst); IRX Therapeutics (Inst); Medpace (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Expert Testimony - Bayer; Doxapharma; GlaxoSmithKline; Health & Life; Ipsen; Kura Oncology; Merck Serono; MSD
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Debiopharm Group; Merck Serono; MSD; SOBI
 
Robert I. Haddad
Employment - Dana-Farber Cancer Institute
Leadership - NCCN
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Genentech; Immunomic Therapeutics; Loxo; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Kura Oncology (Inst); Merck (Inst); Pfizer (Inst); VentiRx (Inst)
 
Caroline Even
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Innate Pharma
 
Makoto Tahara
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Merck Serono; MSD; Ono Pharmaceutical
Consulting or Advisory Role - Amgen; Aspyrian Therapeutics; Bristol-Myers Squibb; Celgene; MSD; Ono Pharmaceutical; Pfizer
Research Funding - Aspyrian Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Loxo (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)
 
Mikhail Dvorkin
No Relationships to Disclose
 
Tudor-Eliade Ciuleanu
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Janssen; Lilly; Merck Serono; Merck Sharp & Dome; Novartis; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - A&D Pharma; Amgen; AstraZeneca; Boehringer Ingelheim; Ipsen; Merck; Pfizer; Sanofi; Servier
 
Paul M. Clement
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); LEO Pharma (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Vifor Pharma (Inst)
Research Funding - AstraZeneca (Inst)
 
Ricard Mesia
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck KGaA; MSD; Nanobiotix; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck KGaA
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck KGaA; Roche
 
Svetlana I. Kutukova
No Relationships to Disclose
 
Lyubov Zholudeva
No Relationships to Disclose
 
Amaury Daste
No Relationships to Disclose
 
Javier Daroqui Caballero
No Relationships to Disclose
 
Bhumsuk Keam
Consulting or Advisory Role - AstraZeneca; Genexine; MSD Oncology
Research Funding - AstraZeneca; MSD Oncology; Ono Pharmaceutical
 
Ihor Vynnychenko
No Relationships to Disclose
 
Cedrik Lafond
No Relationships to Disclose
 
Jagdish Shetty
Employment - AstraZeneca
 
Nassim Morsli
Employment - AstraZeneca
 
Helen Mann
Employment - AstraZeneca
 
Jerome Fayette
Honoraria - AstraZeneca; Biogen; Bristol-Myers Squibb; Innate Pharma; Merck Serono; Merck Sharp & Dohme
Consulting or Advisory Role - AstraZeneca; BIOGEN; Bristol-Myers Squibb; Innate Pharma; Merck Serono; Merck Sharp & Dohme
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme
 
Robert L. Ferris
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono; Lilly; Merck; Pfizer; PPD; Tesaro
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; Tesaro; VentiRx